Eyenovia, Inc.

Julie Whitcomb, PhD Stole the Show at WIO!   Julie Whitcomb, PhD, captivated the audience this weekend at Women in Ophthalmology with her deep dive into the "Effects of APNT™ Nanolization on Ocular Distribution for Clobetasol Propionate." Her presentation shed light on the unique benefits clobetasol offers in ophthalmology, sparking conversations about Eyenovia’s bright future.   Kudos to Julie and everyone at WIO for driving forward the future of eye care!   Couldn’t make it to the session? View the poster here. https://lnkd.in/gTQa5nPs   Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F   #WIO2024 #WomenInOphthalmology #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups

Keep Your Eyes on Innovation at Women in Ophthalmology! Join us in sunny Carlsbad, CA, this Saturday, August 24, as our very own Julie Whitcomb, PhD shares the "Effects of APNT™ Nanolization on Ocular Distribution for Clobetasol Propionate" between 11:05-11:50 AM. Don’t miss this insightful presentation on what makes clobetasol unique to ophthalmology. Session: Poster Session I Monitor: 4 Date: Saturday, August 24 Time: 11:05am - 11:50am Good luck to all the brilliant minds at WIO this weekend—let's make waves in ophthalmology. SCHEDULE: https://lnkd.in/gmdw4b7i Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #WIO2024 #WomenInOphthalmology #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi

In case you missed it! Last week, Glance by Eyes on Eyecare explored the future of dry eye treatment—and Eyenovia was in the spotlight. Their latest article highlights Eyenovia’s innovation and opportunity in the dry eye space, from advanced solutions to a closer look at Clobetasol's potential. Don't miss out on how we're working towards shaping the future of eye care! ARTICLE: https://lnkd.in/gt-U45Dn Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #dryeye

With over 25 years of experience, Dr. Wayne H. Martin, MD, drwaynehmartin.com leads a team of specialized doctors who offer a wide range of services, including optometry, LASIK, treatments for conditions like cataracts, macular degeneration, and glaucoma. Dr. Martin and his team understand the closely interconnected relationship between eye health and overall health, and they choose MydCombi for dilation. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk

Congratulations to CEO Erick Co and Formosa Pharmaceuticals, Inc. as they are now listed on the Taiwan Stock Exchange. We are proud to be partners with such an innovative group.

When it comes to dry eye, we have our bases loaded. We are on the mound and ready to pitch some terrific updates in our game plan to address dry eye disease with a field of options: A New Foundation for Treatment: A potentially faster-acting cyclosporine therapy with SGN Nanopharma Inc Adding On to Existing Therapies: A new class of drug that is being developed for adjunctive treatment with Senju USA, Inc. Alleviating Acute Flare-Ups: Co-developing Clobetasol Propionate Ophthalmic Suspension (0.05%) with Formosa Pharmaceuticals, Inc.   With these all-stars and cutting-edge solutions, Eyenovia is ready to hit it out of the park and take the lead against dry eye! Learn how Eyenovia is making it possible by visiting https://bit.ly/3oEM9Ca #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #dryeye

For over three decades, Beverly Hills Institute of Ophthalmology https://lnkd.in/ganJ5wYz has been regarded as one of the most reputable and technologically advanced eye care providers in the Beverly Hills and South Bay regions. Through personal, concierge-style service, Dr. Billy Pan, MD, and his team deliver eye care that is fully customized for optimal patient satisfaction and excellent results. In line with their commitment to premium and customizable patient care, they choose MydCombi for dilation.   Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F   #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi   Contraindications: Known hypersensitivity to any component of the formulation.   See Full Prescribing Information Here: https://bit.ly/4btbPHk

Eyenovia and SGN Nanopharma, Inc. have entered into a collaboration agreement to unite Optejet technology with SGN's Micellar Nanoparticle Platform (MNP) platform-based cyclosporine formulation. This synergy could introduce an emergent therapy to an estimated 35 million people in the U.S. affected by dry eye disease. Eyenovia CEO Michael Rowe shared, "We believe the power of SGN’s MNP platform, when combined with the Optejet, will result in a more efficacious and better tolerated cyclosporine-based treatment that we believe has the potential to become the standard of care in this multi-billion-dollar addressable market.” We look forward to bringing innovative change and enhanced solutions to the dry eye landscape with SGN Nanopharma. Stay tuned for further developments. Full Press Release: https://lnkd.in/gqhBuaBv Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi #pharma

At PremierMED Ophthalmology (https://premiermedeyes.com) Dr. Michael Imler, MD, provides comprehensive medical eye care services, including eye diseases, vision, and custom eyeglasses. He chooses MydCombi to dilate his patients and help deliver state-of-the-art evidence-based eye care to the Winter Garden community. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk

In case you missed it, renowned professional speaker and optometrist Dr. April Jasper recently engaged in an insightful discussion with Eyenovia CEO and Director Michael Rowe to discuss the newest groundbreaking technology for dilation. Dr. Jasper showcases the innovation behind Eyenovia’s proprietary Optejet® technology and explores the unique and potential benefits of MydCombi.   Learn more about MydCombi: https://bit.ly/mydcombi Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi   Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk